PARP Inhibitor
9 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Homologous Recombination Deficiency in Chinese Ovarian Cancer Patients (NCT05044091) | Xiaoxiang Chen | 2021-09-15 |
| The Clinical Markers for PARP Inhibitors-related Efficacy in Ovarian Cancer (NCT04582552) | Xiaoxiang Chen | 2020-12-15 |
| Phase I/IIa Study of Concomitant Radiotherapy With Olaparib and Temozolomide in Unresectable High Grade Gliomas Patients (NCT03212742) | Centre Francois Baclesse | 2017-09-04 |
Track PARP Inhibitor automatically
Every clearance here is in the API, with alerts when new ones post.